Abstract
AbstractUntil recently, few guidelines were available to assist companies in publishing their clinical trials and, compared to other phases of research, the quality of publications and the processes by which publications are developed have not received much scrutiny. However, guidelines on Good Publication Practice (GPP) for pharmaceutical companies have just been published. These aim to raise the quality of publications and to encourage ethical and responsible publication practices. The GPP guidelines were designed to be used alongside existing guidelines such as those from the International Committee of Medical Journal Editors (ICMJE) and the CONSORT statement. These, and other documents relevant to preparing publications, are reviewed and recommendations for ways in which companies might improve the quality of their publications are proposed. Copyright © 2003 John Wiley & Sons, Ltd.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
